The analysis of clinical features and prognostic factors of borderline ovarian tumors
10.3969/j.issn.1671-8348.2014.08.011
- VernacularTitle:卵巢交界性肿瘤的临床特点及预后影响因素分析
- Author:
Ruying LIANG
- Publication Type:Journal Article
- Keywords:
ovarian neoplasm;
retrospective studies;
factor analysis,statistical;
prognosis
- From:
Chongqing Medicine
2014;(8):927-929
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical features of different pathological borderline ovarian tumors and evaluate its prog-nostic factors .Methods The clinical data of 60 patients were retrospectively analyzed .Based on different histological types ,these patients were divided into serous borderline ovarian tumors group and mucins borderline ovarian tumors group .The clinical features was compared .Results 60 cases of epithelial borderline ovarian tumors contained 22(36 .7% ) serous borderline ovarian tumors and 34(56 .6% ) mucins borderline ovarian tumors .The tumor size ,ratio of bi-laterality ,multi-locular cyst ,papillary patterns ,level of CA-125 or CA19-9 had significant differences between the two groups(P<0 .05) .56 patients were followed up ,the 5-year overall survival and disease-free survival were 96 .8% and 94 .2% ,respectively .Univariate analysis of 5 years disease-free survival showed that ,age ,tumor size ,histological types ,menopause ,operation types ,chemotherapy and level of CA-125 or CA19-9 were irrelevant to prognosis of patients ,and FIGO stage ,micro-invasion ,peritoneal implants were relevant factors to prognosis .Multivariate analyses showed that ,the patients with low stage of FIGO (OR=0 .348 ,P<0 .05) had better prognosis ,while the patients with micro-inva-sion(OR= 8 .458 ,P< 0 .05) ,peritoneal implants (OR= 7 .109 ,P< 0 .05) had worse prognosis .Conclusion Borderline ovarian tumors frequently affected younger patients and has an excellent prognosis .there were some different clinical characteristics be-tween serous borderline ovarian tumors and mucins borderline ovarian tumors .All patients with borderline ovarian tumors should follow-up ,especially these who had high risks as micro-invasion ,peritoneal implants and high FIGO stage .
